What is the most common organ system involved in the pathophysiology of preeclampsia?

Explanation

## Pathophysiology of Preeclampsia: The Central Role of Endothelial Dysfunction **Key Point:** Endothelial dysfunction and systemic vascular injury is the primary pathophysiologic mechanism underlying preeclampsia, not isolated organ disease. This explains the multisystem manifestations of the condition. ### Two-Stage Model of Preeclampsia Pathogenesis ```mermaid flowchart TD A[Abnormal placentation]:::outcome --> B[Placental ischemia & hypoxia]:::outcome B --> C[Release of placental factors]:::outcome C --> D[Circulating sFlt-1 & sEng]:::outcome D --> E[Systemic endothelial dysfunction]:::action E --> F[Increased vascular permeability]:::outcome E --> G[Vasoconstriction & HTN]:::outcome E --> H[Platelet activation & thrombosis]:::outcome E --> I[Renal glomerular injury]:::outcome E --> J[Cerebral vasospasm]:::outcome E --> K[Hepatic sinusoidal injury]:::outcome I --> L[Proteinuria & AKI]:::outcome J --> M[Seizures & hemorrhage]:::outcome K --> N[Hemolysis & LFT elevation]:::outcome ``` ### Molecular Basis of Endothelial Dysfunction **High-Yield:** The key circulating factors in preeclampsia are: 1. **sFlt-1** (soluble fms-like tyrosine kinase-1) - Antagonizes VEGF and PlGF - Reduces nitric oxide production - Increases endothelial permeability 2. **sEng** (soluble endoglin) - Inhibits TGF-β signaling - Promotes endothelial dysfunction 3. **Oxidative stress & inflammation** - Increased reactive oxygen species (ROS) - Reduced antioxidant capacity - Activation of inflammatory cytokines ### Why Endothelial Dysfunction Explains All Manifestations | System | Manifestation | Mechanism | |---|---|---| | **Vascular** | Hypertension, vasoconstriction | Loss of vasodilation; increased sensitivity to angiotensin II | | **Renal** | Proteinuria, AKI | Glomerular endothelial injury; reduced GFR | | **Hematologic** | Thrombocytopenia, hemolysis | Platelet consumption; microangiopathic hemolytic anemia | | **Hepatic** | Elevated transaminases (HELLP) | Sinusoidal endothelial injury; hepatocellular necrosis | | **Neurologic** | Seizures, hemorrhage | Cerebral vasospasm; loss of autoregulation | | **Pulmonary** | Pulmonary edema | Increased capillary permeability | **Clinical Pearl:** The **HELLP syndrome** (Hemolysis, Elevated Liver enzymes, Low Platelets) is a manifestation of severe preeclampsia driven by endothelial dysfunction, not primary liver or blood disease. ### Why Other Options Are Incorrect **Warning:** ~~Primary renal glomerular disease~~ is not the cause; the kidney injury is secondary to endothelial dysfunction. Glomerular endotheliosis (swelling of glomerular endothelial cells) is the pathologic finding, not primary glomerulonephritis. ~~Placental insufficiency alone~~ is the initiating event, but the clinical manifestations result from the systemic endothelial response to placental factors, not placental insufficiency per se. ~~Hepatic synthetic dysfunction~~ is a consequence of endothelial injury in the liver, not the primary mechanism. ### Diagnostic Correlation - **Elevated sFlt-1 and sEng** can be measured in maternal serum (research tool; not routine) - **Glomerular endotheliosis** seen on kidney biopsy (rarely performed) - **Thrombocytopenia** reflects platelet consumption due to endothelial injury [cite:Harrison 21e Ch 297; Williams Obstetrics 26e Ch 34]